Latest Insider Transactions at Evolus, Inc. (EOLS)
This section provides a real-time view of insider transactions for Evolus, Inc. (EOLS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Evolus, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Evolus, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 06
2024
|
Sandra Beaver Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,276
-2.16%
|
$45,864
$14.98 P/Share
|
Aug 30
2024
|
Tomoko Yamagishi Dressler Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
5,631
-6.4%
|
$84,465
$15.85 P/Share
|
Jul 01
2024
|
Albert G White Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
23,014
+50.0%
|
-
|
Jun 06
2024
|
David Moatazedi Director |
SELL
Open market or private sale
|
Direct |
175,940
-24.81%
|
$2,111,280
$12.59 P/Share
|
Jun 06
2024
|
David Moatazedi Director |
BUY
Exercise of conversion of derivative security
|
Direct |
175,940
+19.88%
|
$1,231,580
$7.28 P/Share
|
Jun 05
2024
|
David Moatazedi Director |
SELL
Open market or private sale
|
Direct |
155,278
-22.55%
|
$1,863,336
$12.92 P/Share
|
Jun 05
2024
|
David Moatazedi Director |
BUY
Exercise of conversion of derivative security
|
Direct |
155,278
+18.4%
|
$776,390
$5.46 P/Share
|
Jun 04
2024
|
David Moatazedi Director |
SELL
Open market or private sale
|
Direct |
140,214
-20.82%
|
$1,682,568
$12.73 P/Share
|
Jun 03
2024
|
Vikram Malik Director |
SELL
Open market or private sale
|
Direct |
7,500
-2.95%
|
$90,000
$12.96 P/Share
|
May 14
2024
|
David N Gill Director |
SELL
Open market or private sale
|
Direct |
6,718
-16.51%
|
$80,616
$12.6 P/Share
|
May 13
2024
|
Vikram Malik Director |
SELL
Open market or private sale
|
Direct |
28,000
-9.93%
|
$336,000
$12.93 P/Share
|
May 13
2024
|
David N Gill Director |
SELL
Open market or private sale
|
Direct |
3,643
-8.22%
|
$43,716
$12.72 P/Share
|
May 10
2024
|
Sandra Beaver Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,423
-1.57%
|
$29,076
$12.72 P/Share
|
May 10
2024
|
Rui Avelar Officer |
SELL
Open market or private sale
|
Direct |
3,441
-0.92%
|
$41,292
$12.72 P/Share
|
May 10
2024
|
David Moatazedi Director |
SELL
Open market or private sale
|
Direct |
16,051
-2.33%
|
$192,612
$12.72 P/Share
|
Mar 27
2024
|
David Moatazedi Director |
SELL
Open market or private sale
|
Direct |
6,236
-0.9%
|
$81,068
$13.86 P/Share
|
Mar 19
2024
|
David Moatazedi Director |
SELL
Open market or private sale
|
Direct |
96,566
-12.19%
|
$1,255,358
$13.92 P/Share
|
Mar 19
2024
|
Sandra Beaver Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,672
-3.55%
|
$73,736
$13.92 P/Share
|
Mar 19
2024
|
Rui Avelar Officer |
SELL
Open market or private sale
|
Direct |
27,603
-6.9%
|
$358,839
$13.92 P/Share
|
Feb 22
2024
|
Sandra Beaver Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,821
-1.13%
|
$23,673
$13.08 P/Share
|
Feb 22
2024
|
Rui Avelar Officer |
SELL
Open market or private sale
|
Direct |
1,821
-0.45%
|
$23,673
$13.08 P/Share
|
Feb 22
2024
|
David Moatazedi Director |
SELL
Open market or private sale
|
Direct |
7,706
-0.96%
|
$100,178
$13.08 P/Share
|
Feb 21
2024
|
Sandra Beaver Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,115
+7.5%
|
-
|
Feb 21
2024
|
Rui Avelar Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,115
+3.16%
|
-
|
Feb 21
2024
|
David Moatazedi Director |
BUY
Grant, award, or other acquisition
|
Direct |
61,202
+7.11%
|
-
|
Feb 07
2024
|
David Moatazedi Director |
BUY
Grant, award, or other acquisition
|
Direct |
134,976
+15.45%
|
-
|
Feb 07
2024
|
Rui Avelar Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,211
+8.31%
|
-
|
Feb 07
2024
|
Sandra Beaver Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,211
+19.16%
|
-
|
Feb 07
2024
|
Tomoko Yamagishi Dressler Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
24,648
+50.0%
|
-
|
Feb 07
2024
|
Vikram Malik Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,464
+2.24%
|
-
|
Feb 07
2024
|
Karah Herdman Parschauer Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,464
+14.63%
|
-
|
Feb 07
2024
|
Robert Hayman Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,464
+10.54%
|
-
|
Feb 07
2024
|
Brady Stewart Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,464
+11.2%
|
-
|
Feb 07
2024
|
David N Gill Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,464
+12.73%
|
-
|
Feb 07
2024
|
Simone Blank Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,464
+8.48%
|
-
|
Jan 30
2024
|
Karah Herdman Parschauer Director |
SELL
Open market or private sale
|
Direct |
11,931
-27.63%
|
$155,103
$13.14 P/Share
|
Dec 08
2023
|
David Moatazedi Director |
SELL
Open market or private sale
|
Direct |
31,300
-4.93%
|
$281,700
$9.73 P/Share
|
Dec 06
2023
|
David Moatazedi Director |
SELL
Open market or private sale
|
Direct |
51,348
-7.48%
|
$513,480
$10.09 P/Share
|
Oct 16
2023
|
Medytox Inc. |
SELL
Open market or private sale
|
Direct |
1,690,663
-33.33%
|
$11,834,641
$7.5 P/Share
|
Sep 06
2023
|
Sandra Beaver Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,178
-2.73%
|
$28,602
$9.7 P/Share
|
Aug 21
2023
|
Tomoko Yamagishi Dressler Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
63,358
+50.0%
|
-
|
Aug 16
2023
|
David Moatazedi Director |
SELL
Open market or private sale
|
Direct |
14,778
-2.11%
|
$147,780
$10.27 P/Share
|
Aug 16
2023
|
Sandra Beaver Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,211
-1.86%
|
$22,110
$10.27 P/Share
|
Aug 16
2023
|
Rui Avelar Officer |
SELL
Open market or private sale
|
Direct |
2,211
-0.62%
|
$22,110
$10.27 P/Share
|
Aug 15
2023
|
Vikram Malik Director |
BUY
Open market or private purchase
|
Direct |
174,967
+38.84%
|
$1,224,769
$7.41 P/Share
|
Aug 14
2023
|
David Moatazedi Director |
BUY
Grant, award, or other acquisition
|
Direct |
91,803
+11.57%
|
-
|
Aug 14
2023
|
Sandra Beaver Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,672
+14.21%
|
-
|
Aug 14
2023
|
Rui Avelar Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,672
+5.24%
|
-
|
Aug 11
2023
|
Robert Hayman Director |
BUY
Other acquisition or disposition
|
Indirect |
366
+3.41%
|
-
|
Aug 11
2023
|
Robert Hayman Director |
BUY
Other acquisition or disposition
|
Direct |
218
+0.45%
|
-
|